Document is current
Any future updates will be listed below
-
Authors
Salman, Yasmine
Goloubeva, Julia
Huyghe, Lara
Quenon, Lisa
Tomé, Sandra O.
Hanseeuw, Bernard
,
-
Funding
Funding for this research was provided by:
Fonds De La Recherche Scientifique - FNRS (FRIA40014635)
Fonds De La Recherche Scientifique - FNRS (FNRS40016560.)
Fonds De La Recherche Scientifique - FNRS (FC 95854)
Fonds De La Recherche Scientifique - FNRS (CCL40010417)
Fondation Recherche Alzheimer/Stichting Alzheimer Onderzoek (SAO20240044)
Fondation Recherche Alzheimer/Stichting Alzheimer Onderzoek (SAO20210026)
Fonds Wetenschappelijk Onderzoek (1225725N)
Alzheimer's Association (AARF-24-1300693)
Walloon excellence in life sciences and biotechnology (40010035)
- License Information
-
More Information
Article History
Received: 14 August 2025
Accepted: 23 November 2025
First Online: 10 December 2025
Declarations
:
: The ADNI study was conducted according to Good Clinical Practice guidelines, the Declaration of Helsinki, US 21CFR Part 50 – Protection of Human Subjects, and Part 56 – Institutional Review Boards, and pursuant to state and federal HIPAA regulations. Written informed consent for the study was obtained from all subjects and/or authorized representative. More information can be found in the ADNI documentation.
: S.O.T. received consultant honorary from Muna Therapeutics (Belgium).
